Discussions on novel mechanisms centered on TPD and CGT, alongside AI-driven drug 스피드 바카라 strategies and beyond
[by Yu, Suin] The Korea Drug Development Fund (KDDF) announced that it will host the ‘2025 KDDF Science Conference’ from August 28 to 30 at Alpensia in Pyeongchang, Gangwon Province.
Now in its fifth year, the conference is expected to convene approximately 130 experts representing industry, academia, research institutes, and the medical community. The program will center on advancing research into novel mechanisms and exploring next-generation drug 스피드 바카라 strategies, with particular emphasis on artificial intelligence (AI)-driven technologies, including targeted protein degradation (TPD) and cellular and gene therapy (CGT).
The special lecture was delivered by Cha Kwang-ryeol, Director of the Global Research Institute at Cha Hospital and Cha Bio Group, a globally recognized scholar renowned for pioneering innovations in reproductive medicine. His achievements include the world's first successful pregnancy and live birth using immature oocytes in 1989, the 스피드 바카라 of vitrification-based oocyte cryopreservation in 1998, and the establishment of the world's first egg bank in 1999. At present, Cha Bio Group continues to lead advancements in cutting-edge regenerative medicine, including stem cell-based cell therapy, immune cell therapy, tissue regeneration, and research on delaying aging.
In his lecture, Cha will present on the theme, ‘Measures to Secure Korea's Cell and Gene Therapy Sovereignty and Create Future Growth Engines.’ He will underscore the importance of a dual strategy aimed at securing and certifying both proprietary cell lines and internationally standardized cell lines, a measure designed to reduce licensing costs and accelerate 스피드 바카라 timelines.
The keynote address will be delivered by Dr. Till Alexander Röhn of the multinational pharmaceutical company Novartis Pharma AG, who will present a new approach to the treatment of immune-related diseases. Concluding the conference on August 30, a dedicated session on AI, recognized as a national strategic industry, will explore the application of AI throughout the full spectrum of novel drug 스피드 바카라, while also highlighting the most recent technological advances in the field.
“Over the past four years, the KDDF Science Conference has served as a venue where Korean and international experts in novel drug 스피드 바카라 come together to exchange knowledge, share experiences, and foster mutual growth,” said Park Yeong-min, CEO of KDDF. “This year, by addressing research on novel mechanisms and next-generation drug 스피드 바카라 utilizing AI-based technologies, we anticipate the conference will provide an important opportunity to advance the 스피드 바카라 of innovative new drugs,” he added.